会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Method for treating multi-drug resistant tumors
    • 多药耐药肿瘤治疗方法
    • US07303760B2
    • 2007-12-04
    • US10714085
    • 2003-11-14
    • Samuel ZalipskyAlberto Gabizon
    • Samuel ZalipskyAlberto Gabizon
    • A61K9/127C07F9/02C07F53/00C07F321/00
    • A61K31/407A61K47/543A61K47/6911
    • Methods for administering mitomycin C to a multi-drug resistant cell and for reducing the toxicity of the compound are described. In the methods, mitoymic C is provided in the form of a prodrug conjugate, where the drug is linked to a hydrophobic moiety, such as a lipid, through a cleavable dithiobenzyl linkage. The dithiobenzyl linkage is susceptible to cleavage by mild thiolysis, resulting in release of mitomycin C in its original form. The linkage is stable under nonreducing conditions. The prodrug conjugate can be incorporated into liposomes for administration in vivo and release of mitomycin C in response to endogenous in vivo reducing conditions or in response to administration of an exogenous reducing agent.
    • 描述了向多药耐药细胞施用丝裂霉素C并降低化合物的毒性的方法。 在该方法中,丝裂蛋白C以前体药物缀合物的形式提供,其中药物通过可裂解的二硫代苄基键连接到疏水部分,例如脂质。 二硫代苄基键易受到轻度硫解的裂解,导致丝裂霉素C以其原始形式释放。 在非还原条件下,连接是稳定的。 可以将前体药物缀合物掺入用于体内施用的体内脂质体中,并响应内源性体内还原条件或响应外源性还原剂的施用而释放丝裂霉素C.